E. coli-Derived L-Asparaginase Retains Enzymatic and Cytotoxic Activity In Vitro for Canine and Feline Lymphoma after Cold Storage
Background. L-asparaginase is effective in treating canine and feline lymphoma, however chemotherapy poses a significant financial cost to veterinary clients, limiting therapy for many pets. Single dose vials result in significant drug wastage, and drug shortages limit consistent availability for pe...
Main Authors: | Jackie M. Wypij, Holly C. Pondenis |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | Veterinary Medicine International |
Online Access: | http://dx.doi.org/10.1155/2013/786162 |
Similar Items
-
The Efficacy and Toxicity of Continuously L-asparaginase Administration on relapsed Canine Lymphoma
by: Jun-Hong Wu, et al.
Published: (2010) -
Pamidronate Disodium for Palliative Therapy of Feline Bone-Invasive Tumors
by: Jackie M. Wypij, et al.
Published: (2014-01-01) -
Studies on the differences of asparaginase sensitive and asparaginase resistant forms of 6C3 HED lymphoma
by: Wilson, R.
Published: (1985) -
Magnetic resonance findings of the corpus callosum in canine and feline lysosomal storage diseases.
by: Daisuke Hasegawa, et al.
Published: (2013-01-01) -
Physiology of L-asparaginase synthesis by Escherichia coli
by: Barnes, Wayne Riley
Published: (1979)